These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 11817766
1. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Kampman KM, Volpicelli JR, Mulvaney F, Rukstalis M, Alterman AI, Pettinati H, Weinrieb RM, O'Brien CP. Addict Behav; 2002; 27(2):251-60. PubMed ID: 11817766 [Abstract] [Full Text] [Related]
2. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Kampman KM, Alterman AI, Volpicelli JR, Maany I, Muller ES, Luce DD, Mulholland EM, Jawad AF, Parikh GA, Mulvaney FD, Weinrieb RM, O'Brien CP. Psychol Addict Behav; 2001 Mar; 15(1):52-9. PubMed ID: 11255939 [Abstract] [Full Text] [Related]
3. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Ahmadi J, Kampman KM, Oslin DM, Pettinati HM, Dackis C, Sparkman T. Am J Addict; 2009 Mar; 18(1):81-6. PubMed ID: 19219669 [Abstract] [Full Text] [Related]
4. Outcome predictors in cocaine dependence treatment trials. Ahmadi J, Kampman K, Dackis C. Am J Addict; 2006 Mar; 15(6):434-9. PubMed ID: 17182445 [Abstract] [Full Text] [Related]
8. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Oliveto A, Poling J, Mancino MJ, Williams DK, Thostenson J, Pruzinsky R, Gonsai K, Sofuoglu M, Gonzalez G, Tripathi S, Kosten TR. Addiction; 2012 Jan; 107(1):131-41. PubMed ID: 21707811 [Abstract] [Full Text] [Related]
9. Reliability and validity of the Cocaine Selective Severity Assessment. Kampman KM, Volpicelli JR, McGinnis DE, Alterman AI, Weinrieb RM, D'Angelo L, Epperson LE. Addict Behav; 1998 Jan; 23(4):449-61. PubMed ID: 9698974 [Abstract] [Full Text] [Related]
10. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Kampman KM, Dackis C, Lynch KG, Pettinati H, Tirado C, Gariti P, Sparkman T, Atzram M, O'Brien CP. Drug Alcohol Depend; 2006 Nov 08; 85(2):129-37. PubMed ID: 16697124 [Abstract] [Full Text] [Related]
11. Correlates of polysomnographic sleep changes in cocaine dependence: self-administration and clinical outcomes. Angarita GA, Canavan SV, Forselius E, Bessette A, Morgan PT. Drug Alcohol Depend; 2014 Oct 01; 143():173-80. PubMed ID: 25124303 [Abstract] [Full Text] [Related]
12. Baseline prediction of 7-month cocaine abstinence for cocaine dependence patients. Alterman AI, McKay JR, Mulvaney FD, Cnaan A, Cacciola JS, Tourian KA, Rutherford MJ, Merikle EP. Drug Alcohol Depend; 2000 Jun 01; 59(3):215-21. PubMed ID: 10812282 [Abstract] [Full Text] [Related]
13. DHEAS and POMS measures identify cocaine dependence treatment outcome. Wilkins JN, Majewska MD, Van Gorp W, Li SH, Hinken C, Plotkin D, Setoda D. Psychoneuroendocrinology; 2005 Jan 01; 30(1):18-28. PubMed ID: 15358439 [Abstract] [Full Text] [Related]
14. Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms. Kampman KM, Volpicelli JR, Alterman AI, Cornish J, O'Brien CP. Am J Psychiatry; 2000 Dec 01; 157(12):2052-4. PubMed ID: 11097979 [Abstract] [Full Text] [Related]
15. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FG. J Clin Psychopharmacol; 2001 Oct 01; 21(5):522-6. PubMed ID: 11593078 [Abstract] [Full Text] [Related]
16. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J. JAMA Psychiatry; 2015 Jun 01; 72(6):593-602. PubMed ID: 25887096 [Abstract] [Full Text] [Related]
17. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP. Neuropsychopharmacology; 2005 Jan 01; 30(1):205-11. PubMed ID: 15525998 [Abstract] [Full Text] [Related]
18. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. J Clin Psychopharmacol; 2014 Apr 01; 34(2):234-9. PubMed ID: 24525654 [Abstract] [Full Text] [Related]
19. How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A, Brooks DJ, Nunes EV, Grabowski J. Drug Alcohol Depend; 2018 Jul 01; 188():135-140. PubMed ID: 29775957 [Abstract] [Full Text] [Related]
20. Pemoline for the treatment of cocaine dependence in methadone-maintained patients. Margolin A, Avants SK, Kosten TR. J Psychoactive Drugs; 1996 Jul 01; 28(3):301-4. PubMed ID: 8895115 [Abstract] [Full Text] [Related] Page: [Next] [New Search]